Spero Therapeutics, Inc.SPRONASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank100
3Y CAGR+3.9%
5Y CAGR+4.6%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+3.9%/yr
Annual compound
5Y CAGR
+4.6%/yr
Consistent
Percentile
P100
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.09 | +79.7% |
| 2023 | 0.05 | -40.8% |
| 2022 | 0.09 | +5.4% |
| 2021 | 0.08 | +40.0% |
| 2020 | 0.06 | -20.2% |
| 2019 | 0.07 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |
| 2015 | 0.00 | - |